Pharmacosmedics SA
Pharmacosmedics reported total assets of 289,301 € at the end of the 2026 financial year (annual accounts filed with the NBB on 30 Oct 2026).
The score of Pharmacosmedics shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2026
Change 2023 → 2026: Equity -21 % Total assets -13 %
Accounts of the company itself (not consolidated).
The full file covers 11 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharmacosmedics's annual accounts
Filed annual accounts
- Year ended 31 Mar 2026filed on 30 Oct 2026
- Year ended 31 Mar 2025filed on 28 Oct 2025
- Year ended 31 Mar 2024filed on 25 Oct 2024
- Year ended 31 Mar 2023filed on 30 Oct 2023
- Year ended 31 Mar 2022filed on 04 Nov 2022
Pharmacosmedics's financial analysis
- Solvency32.5%sector median: 60.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharmacosmedics
Pharmacosmedics's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0883.434.923
- VAT number
- BE0883434923
- Peppol
- Registered · 0208:0883434923 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 29 Aug 2006
- Registered office
- 8301 Knokke-Heist
- Latest accounts
- 2026 · filed on 30 Oct 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
Pharmacosmedics (SA) has been based in Knokke-Heist since 2006, active in: research and experimental development on biotechnology. For 2026, it reports a net profit of 5,183 € and equity of 94,092 €; its revenue is not published. Its solvency stands at 32.5%, below the median of its sector (60.4%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Pharmacosmedics
Companies in the same business, of comparable size and area, outside its group.
- Ergotrics Research and experimental development on natural sciences and engineering Turnhout · balance sheet 376,384 €
- Flindr Labs Manufacture of pharmaceutical preparations Ghent · balance sheet 262,929 €
- SciLife Consulting Research and experimental development on natural sciences and engineering Kortenberg · balance sheet 198,474 €
- Orineo Research and experimental development on natural sciences and engineering Kortenberg · balance sheet 394,122 €
- Ferrons Research and experimental development on natural sciences and engineering Ternat · balance sheet 231,903 €
- BONT Research and experimental development on natural sciences and engineering Kasterlee · balance sheet 307,284 €
- Mentana DX Research and experimental development on natural sciences and engineering Evergem · balance sheet 229,998 €
- MY Health International Manufacture of basic pharmaceutical products Lummen · balance sheet €1.04m
Frequently asked questions about Pharmacosmedics
What is the revenue of Pharmacosmedics?
Pharmacosmedics files its accounts in a format where revenue is optional: it is not published for 2026.
What is the VAT number of Pharmacosmedics?
In Belgium, the VAT number is the company number prefixed with BE: BE0883434923 for Pharmacosmedics, if the company is VAT-registered. Its company number (CBE) is 0883.434.923.
Where is the registered office of Pharmacosmedics?
According to the CBE register, the registered office of Pharmacosmedics is in 8301 Knokke-Heist.
What is the equity of Pharmacosmedics?
At the close of the 2026 financial year, the equity of Pharmacosmedics amounts to 94,092 €, a solvency of 32.5% of total assets.
Who manages Pharmacosmedics?
The register lists 5 active mandates at Pharmacosmedics. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharmacosmedics
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →